Evaluation of Multi-feature Auditory Deviance Detection in Parkinson's Disease: a Mismatch Negativity Study

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2021 Apr 25

PMID 33895941

Citations 1

Authors

Evelien De Groote

Annelies Bockstael

Dick Botteldooren

Patrick Santens

Miet De Letter

Affiliations

Soon will be listed here.

Abstract

Behavioral studies on auditory deviance detection in patients with Parkinson's disease (PD) have reported contradictory results. The primary aim of this study was to investigate auditory deviance detection of multiple auditory features in patients with PD by means of objective and reliable electroencephalographic (EEG) measurements. Twelve patients with early-stage PD and twelve age- and gender-matched healthy controls (HCs) were included in this study. Patients with PD participated without their regular dopaminergic medication. All subjects underwent an audiometric screening and performed a passive multi-feature mismatch negativity (MMN) paradigm. Repeated-measures analysis of variance (ANOVA) demonstrated no significant differences between patients with PD and HCs regarding MMN mean amplitude and latency for frequency, duration and gap deviants. Nevertheless, a trend towards increased MMN mean amplitude and latency was found in response to intensity deviants in patients with PD compared to HCs. Increased intensity MMN amplitude may indicate that more neural resources are allocated to the processing of intensity deviances in patients with PD compared to HCs. The interpretation of this intensity-specific MMN alteration is further discussed in the context of a compensatory mechanism for auditory intensity processing and involuntary attention switching in PD.

Citing Articles

What Do Mismatch Negativity (MMN) Responses Tell Us About Tinnitus?.

Yukhnovich E, Alter K, Sedley W J Assoc Res Otolaryngol. 2024; 26(1):33-47.

PMID: 39681798 PMC: 11861849. DOI: 10.1007/s10162-024-00970-1.

References

Abur D, Stepp C . Acuity to Changes in Self-Generated Vocal Pitch in Parkinson's Disease. J Speech Lang Hear Res. 2020; 63(9):3208-3214. PMC: 7890224. DOI: 10.1044/2020_JSLHR-20-00003. View

Abur D, Lester-Smith R, Daliri A, Lupiani A, Guenther F, Stepp C . Sensorimotor adaptation of voice fundamental frequency in Parkinson's disease. PLoS One. 2018; 13(1):e0191839. PMC: 5786318. DOI: 10.1371/journal.pone.0191839. View

Annanmaki T, Palmu K, Murros K, Partanen J . Altered N100-potential associates with working memory impairment in Parkinson's disease. J Neural Transm (Vienna). 2017; 124(10):1197-1203. DOI: 10.1007/s00702-017-1758-z. View

Artieda J, Pastor M, Lacruz F, Obeso J . Temporal discrimination is abnormal in Parkinson's disease. Brain. 1992; 115 Pt 1:199-210. DOI: 10.1093/brain/115.1.199. View

Benoit C, Bella S, Farrugia N, Obrig H, Mainka S, Kotz S . Musically cued gait-training improves both perceptual and motor timing in Parkinson's disease. Front Hum Neurosci. 2014; 8:494. PMC: 4083221. DOI: 10.3389/fnhum.2014.00494. View

Bertram M, Warren C, Lange F, Seer C, Steinke A, Wegner F . Dopaminergic modulation of novelty repetition in Parkinson's disease: A study of P3 event-related brain potentials. Clin Neurophysiol. 2020; 131(12):2841-2850. DOI: 10.1016/j.clinph.2020.09.013. View

Boecker H, Ceballos-Baumann A, Bartenstein P, Weindl A, Siebner H, Fassbender T . Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain. 1999; 122 ( Pt 9):1651-65. DOI: 10.1093/brain/122.9.1651. View

Boutros N, Belger A . Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry. 1999; 45(7):917-22. DOI: 10.1016/s0006-3223(98)00253-4. View

Bronnick K, Nordby H, Larsen J, Aarsland D . Disturbance of automatic auditory change detection in dementia associated with Parkinson's disease: A mismatch negativity study. Neurobiol Aging. 2008; 31(1):104-13. DOI: 10.1016/j.neurobiolaging.2008.02.021. View

10.

CANTER G . SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE: I. INTENSITY, PITCH, AND DURATION. J Speech Hear Disord. 1963; 28:221-9. DOI: 10.1044/jshd.2803.221. View

11.

Carson N, Leach L, Murphy K . A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2017; 33(2):379-388. DOI: 10.1002/gps.4756. View

12.

Cavanagh J, Kumar P, Mueller A, Pirio Richardson S, Mueen A . Diminished EEG habituation to novel events effectively classifies Parkinson's patients. Clin Neurophysiol. 2018; 129(2):409-418. PMC: 5999543. DOI: 10.1016/j.clinph.2017.11.023. View

13.

Chang Y, Xu J, Pang X, Sun Y, Zheng Y, Liu Y . Mismatch negativity indices of enhanced preattentive automatic processing in panic disorder as measured by a multi-feature paradigm. Biol Psychol. 2015; 105:77-82. DOI: 10.1016/j.biopsycho.2015.01.006. View

14.

Chaudhuri K, Schapira A . Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009; 8(5):464-74. DOI: 10.1016/S1474-4422(09)70068-7. View

15.

Clark J, Adams S, Dykstra A, Moodie S, Jog M . Loudness perception and speech intensity control in Parkinson's disease. J Commun Disord. 2014; 51:1-12. DOI: 10.1016/j.jcomdis.2014.08.001. View

16.

DARLEY F, Aronson A, Brown J . Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969; 12(2):246-69. DOI: 10.1044/jshr.1202.246. View

17.

De Keyser K, Santens P, Bockstael A, Botteldooren D, Talsma D, De Vos S . The Relationship Between Speech Production and Speech Perception Deficits in Parkinson's Disease. J Speech Lang Hear Res. 2016; 59(5):915-931. DOI: 10.1044/2016_JSLHR-S-15-0197. View

18.

De Keyser K, De Letter M, De Groote E, Santens P, Talsma D, Botteldooren D . Systematic Audiological Assessment of Auditory Functioning in Patients With Parkinson's Disease. J Speech Lang Hear Res. 2019; 62(12):4564-4577. DOI: 10.1044/2019_JSLHR-H-19-0097. View

19.

De Keyser K, De Letter M, Santens P, Talsma D, Botteldooren D, Bockstael A . Neurophysiological investigation of auditory intensity dependence in patients with Parkinson's disease. J Neural Transm (Vienna). 2021; 128(3):345-356. DOI: 10.1007/s00702-021-02305-3. View

20.

Defer G, Widner H, Marie R, Remy P, Levivier M . Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord. 1999; 14(4):572-84. DOI: 10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c. View